North America Cell Line Development Market 2027 By Type, By Product, Application, and Geography

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

North America Cell Line Development Market to 2027 - Regional Analysis and Forecasts by Type (Primary Cell Line, Hybridomas, Continuous Cell Lines, and Recombinant Cell Line); By Product (Equipment and Media & Reagent); Application (Drug Discovery, Bioproduction and Tissue Engineering); and Geography

  • Report Code : TIPRE00009033
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 145
Buy Now

Cell Line Development market in North America is expected to grow from US$ 1,393.32 Mn in 2019 to US$ 3,829.46 Mn by the year 2027. This represents a CAGR of 13.5% from the year 2020 to 2027.

 

The growth of the Cell Line Development market is driven by the factors such as increase in the demand for innovative products from biopharmaceutical and biotechnology companies, the presence of key market players, and extensive R&D conducted by various academic and research institutes in the North America region.

The medical biotechnology has undergone revolutions as a result of various development programs, business strategies that helps to produce, discover, or alter various biomolecules and organisms through bioengineering approaches. The Biotech Startup Revolution has also assisted in promoting the new ventures holding promising and innovative ideas in the country and supported in maximizing the revenue generation and thus the economic position of North America in the global cell line development market.

Moreover, increasing focus on advanced method incorporation in healthcare, government, and private initiatives for promotion of precision medicine and massive funds from government and private bodies for genomic research are further expected to stimulate growth and contribute to exceptional revenue generation for the cell line development market in North America.

US is anticipated to lead the adoptions of cell line development across the North American region through the forecast period. The increasing investments and rising funds dedicated to the manufacturing companies as well as academic and research institutes for the development of cell line based end products such as precision medicine and other therapeutics is one of the major driving factors. In 2018, The All of Us Research Program of NIH funded the Genome Centers in generating genotype sequence data from bio samples. These factors are expected to accelerate market growth over the forecast years.


Mexico Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)

Mexico Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.


NORTH AMERICA CELL LINE DEVELOPMENT - MARKET SEGMENTATION

North America Cell Line Development Market - By Type

  • Recombinant Cell Line
  • Hybridomas
  • Primary Cell Line
  • Continuous Cell Lines

North America Cell Line Development Market - By Product

  • Media and Reagent
  • Equipment

North America Cell Line Development Market - By Application

  • Bioproduction
  • Drug Discovery
  • Tissue Engineering

North America Cell Line Development Market - By Country

  • U.S.
  • Canada
  • Mexico

Companies Mentioned

  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Sartorius AG
  • SELEXIS
  • BioFactura, Inc.
  • WuXi AppTec
  • LakePharma, Inc.
  • General Electric Company
  • Lonza
  • Corning Incorporated

North America Cell Line Development Report Scope

Report Attribute Details
Market size in 2019 US$ 1,393.32 Million
Market Size by 2027 US$ 3,829.46 Million
Global CAGR (2020 - 2027) 13.5%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Type
  • Primary Cell Line
  • Hybridomas
  • Continuous Cell Lines
  • Recombinant Cell Line
By Product
  • Equipment and Media & Reagent
By Application
  • Drug Discovery
  • Bioproduction and Tissue Engineering
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Sartorius AG
  • SELEXIS
  • BioFactura, Inc.
  • WuXi AppTec
  • LakePharma, Inc.
  • General Electric Company
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    north-america-cell-line-development-market-report-deliverables-img1
    north-america-cell-line-development-market-report-deliverables-img2
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    Type, By Product, Application, and Geography

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    US, Canada

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    The List of Companies - North America Cell Line Development Market

     

    1. Merck KGaA
    2. Thermo Fisher Scientific, Inc.
    3. Sartorius AG
    4. SELEXIS
    5. BioFactura, Inc.
    6. WuXi AppTec
    7. LakePharma, Inc.
    8. General Electric Company
    9. Lonza
    10. Corning Incorporated

     

    north-america-cell-line-development-market-cagr